-
Symbol
-
NAMS on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, Nominal value 0.12 per share
-
Latest Disclosed Ownership
-
7.33M shares
-
Security Ownership
-
6.5%
Frazier Life Sciences X, L.P. ownership in NewAmsterdam Pharma Co N.V. Ordinary Shares, Nominal value 0.12 per share (NAMS)
2025-08-20 - Frazier Life Sciences X, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.33M shares of NewAmsterdam Pharma Co N.V. Ordinary Shares, Nominal value 0.12 per share (NAMS).
This represents 6.5% percent ownership of the company.